Klára Brožová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Klára Brožová has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Ema Povolná
LF UK FN Motol, Interni Klin 2, Prague, Czech Republic
2 shared publicationsJan Brož
LF UK FN Motol, Interni Klin 2, Prague, Czech Republic
2 shared publications- Jan Brož
Interní klinika
2 shared publications Juraj Michalec
LF UK FN Motol, Interni Klin 2, Prague, Czech Republic
2 shared publicationsMarek Brabec
AV CR, Ustav Informat, v v i, Prague, Czech Republic
2 shared publicationsPavel Kohout
3 LF UK Praha, Prague, Czech Republic
2 shared publications
Latest Publications
- Open Access
- 29 May 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 57, 72-81
Key lessons from the first international treatment eligibility committee: the case of metachromatic leukodystrophy
- 29 May 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 57, 72-81
Open AccessKey lessons from the first international treatment eligibility committee: the case of metachromatic leukodystrophy
- 30 April 2024
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 87/120 (2) , 89-95
Hypoglycemia as a complication of diabetes mellitus treatment acute eff ect on central nervous system function
- 30 April 2024
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 87/120 (2) , 89-95
Hypoglycemia as a complication of diabetes mellitus treatment acute eff ect on central nervous system function
- Open Access
- 4 July 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (3) , 1021-1027
Dynamics of glucose concentration during the initiation of ketogenic diet treatment in children with refractory epilepsy: Results of continuous glucose monitoring
Objective: The ketogenic diet (KD) is a diet low in carbohydrates and rich in fats which has long been used to treat refractory epilepsy. The metabolic changes related to the KD may increase the risk of hypoglycemia, especially during the first days. The study focused on the impact of KD initiation on glycemia in non‐diabetic patients with refractory epilepsy.Methods: The subjects were 10 pediatric patients (6 boys, mean age 6.1 ± 2.4 years), treated for intractable epilepsy. Blinded continuous glucose monitoring system (CGM) Dexcom G4 was used. Patients started on their regular diet in the first 36 hours of monitoring, followed by an increase in lipids intake and a gradual reduction of carbohydrates (relations 1:1; 2:1; 3:1; 3.5:1). We analyzed changes in glycemia during fat: nonfat ratio changes using a generalized linear model.Results: The mean monitored time per person was 6 days, 10 hours and 44 minutes. The mean ± SD glycemia for the regular diet was 4.84 ± 0.20 mmol/L, for the carbohydrates/fat ratio of 1:1 it was 4.03 ± 0.16, for the ratio of 2:1 it was 3.57 ± 0.10, for the ratio 3:1 it was 3.39 ± 0.13 and for the final ratio of 3.5:1 it was 2.79 ± 0.06 mmol/L (P < 0.001). The portions of time spent in glycemia ≤3.5 mmol/L (≤2.5 mmol/L respectively) were: on the normal diet 0.88% (0.31%) of the monitored period, during 1:1 KD ratio 1.92% (0.95%), during 2:1 ratio 3.18% (1.02%), and during 3:1 and 3.5:1 ratios 13.64% (2.36%) of the monitored time (P < 0.05).Significance: Continuous glucose monitoring system shows the dynamic of glucose concentration in ketogenic diet treatment initiation. It may be a useful tool to control the effects of this diet on glucose metabolism, especially in hypoglycemia detection.
- 4 July 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (3) , 1021-1027
Open AccessDynamics of glucose concentration during the initiation of ketogenic diet treatment in children with refractory epilepsy: Results of continuous glucose monitoring
Objective: The ketogenic diet (KD) is a diet low in carbohydrates and rich in fats which has long been used to treat refractory epilepsy. The metabolic changes related to the KD may increase the risk of hypoglycemia, especially during the first days. The study focused on the impact of KD initiation on glycemia in non‐diabetic patients with refractory epilepsy.Methods: The subjects were 10 pediatric patients (6 boys, mean age 6.1 ± 2.4 years), treated for intractable epilepsy. Blinded continuous glucose monitoring system (CGM) Dexcom G4 was used. Patients started on their regular diet in the first 36 hours of monitoring, followed by an increase in lipids intake and a gradual reduction of carbohydrates (relations 1:1; 2:1; 3:1; 3.5:1). We analyzed changes in glycemia during fat: nonfat ratio changes using a generalized linear model.Results: The mean monitored time per person was 6 days, 10 hours and 44 minutes. The mean ± SD glycemia for the regular diet was 4.84 ± 0.20 mmol/L, for the carbohydrates/fat ratio of 1:1 it was 4.03 ± 0.16, for the ratio of 2:1 it was 3.57 ± 0.10, for the ratio 3:1 it was 3.39 ± 0.13 and for the final ratio of 3.5:1 it was 2.79 ± 0.06 mmol/L (P < 0.001). The portions of time spent in glycemia ≤3.5 mmol/L (≤2.5 mmol/L respectively) were: on the normal diet 0.88% (0.31%) of the monitored period, during 1:1 KD ratio 1.92% (0.95%), during 2:1 ratio 3.18% (1.02%), and during 3:1 and 3.5:1 ratios 13.64% (2.36%) of the monitored time (P < 0.05).Significance: Continuous glucose monitoring system shows the dynamic of glucose concentration in ketogenic diet treatment initiation. It may be a useful tool to control the effects of this diet on glucose metabolism, especially in hypoglycemia detection.
- 6 April 2022
- Published by Elsevier in Canadian Journal of Diabetes
- Vol. 46 (7) , 743-749.e4
Optimal Carbohydrate Dose for Treatment of Nonsevere Hypoglycemia in Insulin-Treated Patients With Diabetes: A Narrative Review
- 6 April 2022
- Published by Elsevier in Canadian Journal of Diabetes
- Vol. 46 (7) , 743-749.e4
Optimal Carbohydrate Dose for Treatment of Nonsevere Hypoglycemia in Insulin-Treated Patients With Diabetes: A Narrative Review
- 1 January 2021
- Vol. 42 (4) , 277-281
Hypoglycemia during treatment with the ketogenic diet in a child with refractory epilepsy-results of continuous glucose monitoring
The ketogenic diet (KD) is an effective treatment for intractable epilepsy in children. Hypoglycemia can be one of its side-effects, which is considered to be present mainly during the introductory phase of KD. Continuous glucose monitoring in a 6-year old non-diabetic child treated with KD for more than 8 months revealed long periods of asymptomatic hypoglycemia (8.9% of the total time under 2.5 mmol/l, 10.6% of the total time in the range between 2.5-3.0, 29.1% in the range of 3.0-3.6 mmol/l). The episodes of serious hypoglycemia were associated with a fasting state. The amount of sacharides in KD was increased with substantial glycemic profile improvement.
- 1 January 2021
- Vol. 42 (4) , 277-281
Hypoglycemia during treatment with the ketogenic diet in a child with refractory epilepsy-results of continuous glucose monitoring
The ketogenic diet (KD) is an effective treatment for intractable epilepsy in children. Hypoglycemia can be one of its side-effects, which is considered to be present mainly during the introductory phase of KD. Continuous glucose monitoring in a 6-year old non-diabetic child treated with KD for more than 8 months revealed long periods of asymptomatic hypoglycemia (8.9% of the total time under 2.5 mmol/l, 10.6% of the total time in the range between 2.5-3.0, 29.1% in the range of 3.0-3.6 mmol/l). The episodes of serious hypoglycemia were associated with a fasting state. The amount of sacharides in KD was increased with substantial glycemic profile improvement.
- 1 September 2019
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 184, 105400
Megalencephalic leukoencephalopathy with subcortical cysts without macrocephaly: A case study of comorbid Turner’s syndrome
- 1 September 2019
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 184, 105400
Megalencephalic leukoencephalopathy with subcortical cysts without macrocephaly: A case study of comorbid Turner’s syndrome